J&J beats forecast, but 2013 view lags expectations

(Reuters) – Johnson & Johnson reported better-than-expected fourth-quarter earnings on Tuesday, but took another big special charge for its recalled artificial hips and forecast 2013 earnings below Wall Street forecasts. The diversified healthcare company said it earned $2.6 billion (1.6 billion pounds), or 91 cents per share. …

Related Post

Comments are closed.